Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galectin Therapeutics Inc (NASDAQ:GALT)

1.22
Delayed Data
As of Sep 29
 -0.18 / -12.86%
Today’s Change
1.08
Today|||52-Week Range
3.25
-25.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization9.0K12.0K10.0K7.0K
 
 
 
 
 
 
Operating ExpensesGross Income-9.0K-12.0K-10.0K-7.0K
 
 
 
 
 
General Expenses9.9M12.1M15.3M20.1M
 
 
 
 
 
Research And Development4.5M5.7M8.4M13.1M
 
 
 
 
 
Total Operating Expenses9.9M12.1M15.3M20.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.9M-12.1M-15.3M-20.1M
 
 
 
 
 
Extraordinary Credit200.0K0.000.000.00
 
 
Extraordinary Charge0.000.00-150.0K0.00
 
 
Pre-Tax Equity Earnings0.00---400.0K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.7M-12.1M-15.8M-20.0M
 
 
 
 
 
Preferred Dividend-976.0K-867.0K-943.0K-1.1M
 
 
 
 
 
Net Income-9.9M-21.1M-16.0M-20.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.1M16.9M21.8M24.1M
 
 
 
 
 
Shares To Calculate EPS Diluted15.1M16.9M21.8M24.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.72-$1.30-$0.78-$0.88
 
 
 
 
 
EPS Diluted-$0.72-$1.30-$0.78-$0.88